Ursodeoxycholic Acid
Ursodeoxycholic Acid is a pharmaceutical drug with 57 clinical trials. Currently 5 active trials ongoing. Historical success rate of 82.1%.
Success Metrics
Based on 23 completed trials
Phase Distribution
Phase Distribution
7
Early Stage
18
Mid Stage
21
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
74.2%
23 of 31 finished
25.8%
8 ended early
5
trials recruiting
57
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Comparative Evaluation of Oral Ursodeoxycholic Acid in Reducing Bilirubin Levels Among Patients With Acute Viral Hepatitis
Efficacy & Safety of Oral Adjuvants to Phototherapy in Neonatal Hyperbilirubinemia
Effect of Ursodeoxycholic Acid Supplementation on Liver Regeneration on Right Lobe Donor Hepatectomy
Efficacy and Safety of Ursodeoxycholic Acid in Reversing Gastric Intestinal Metaplasia
Ursodeoxycholic Acid vs Metformin in Gestational Diabetes Mellitus
Clinical Trials (57)
Comparative Evaluation of Oral Ursodeoxycholic Acid in Reducing Bilirubin Levels Among Patients With Acute Viral Hepatitis
Efficacy & Safety of Oral Adjuvants to Phototherapy in Neonatal Hyperbilirubinemia
Effect of Ursodeoxycholic Acid Supplementation on Liver Regeneration on Right Lobe Donor Hepatectomy
Efficacy and Safety of Ursodeoxycholic Acid in Reversing Gastric Intestinal Metaplasia
Ursodeoxycholic Acid vs Metformin in Gestational Diabetes Mellitus
Clinical Research of Tapering UDCA in PBC Patients With a Complete Response
Performance of Scoring Systems in Chinese Patients With Primary Biliary Cholangitis (PBC) on Ursodeoxycholic Acid
Ursodeoxycolic Acid for the Prevention of Relapsing Complications After Gallstone Acute Pancreatitis
The Application of Ursodeoxycholic Acid for the Prevention of SARS-CoV-2 Infection (COVID-19)
Ursodeoxycholic Acid in C. Difficile Infection
Ursodeoxycholic Acid as add-on Therapy in Type 2 Diabetes Mellitus
Ursodeoxycholic Acid (UDCA) for Hepatic Sarcoidosis
UDCA in the Treatment of COVID-19 Infection and Its Clinical Prognosis in Patients With Autoimmune Liver Disease
Prophylactic Effect of Nirmatrelvir/Ritonavir and Ursodeoxycholic Acid on Reducing Complications After Cardiac Surgery
Pancreatic Enzymes and Bile Acids in Acutely Ill Severely Malnourished Children
A Study to Compare P1101 Plus TAF With or Without UDCA in Patients With HBV and HDV Co-Infection
Follow-up of NAFLD Patients With MRI-PDFF
Treatment Efficacy of Corticosteroids and Mycophenolate Mofetil in Patients With Immune Related Hepatitis
Brain Bioenergetics in Parkinson's Disease and Response to Repeated Oral UDCA Treatment
Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 57